BIOSPECIFICS TECH CORP has a total of 17 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are VELLEJA RES S R L, MEDY TOX INC and GESTILAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Japan | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Enzymes | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Specific use of cosmetics | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Wegman Thomas L | 15 |
#2 | Yu Bo | 10 |
#3 | Leppert Phyllis Carolyn | 5 |
#4 | Phyllis Carolyn Leppert | 2 |
#5 | Taylor Darlene K | 2 |
#6 | Thomas L Wegman | 2 |
Publication | Filing date | Title |
---|---|---|
US2019071659A1 | Compositions and methods for producing clostridial collagenases | |
CA2998582A1 | Thermosensitive hydrogel collagenase formulations | |
US2014287032A1 | Treatment method and product for uterine fibroids using purified collagenase |